Chikungunya is a viral infection transmitted through mosquito bites, often resulting in debilitating fever and persistent joint pain. In this case study, a patient contracted the virus four years ago, leading to a progressive increase in chronic pain. For the first two years, she managed her symptoms with over-the-counter ibuprofen; however, as the condition worsened, her pain levels escalated to an eight out of ten, severely impacting her mobility and quality of life.
To address her condition, the patient utilized a combination of homeopathic constitutional remedies alongside in-clinic coMra therapy using the coMra Delta. While questions often arise regarding the efficacy of coMra therapy for tick-borne illnesses like Lyme disease, this specific case focused on the lingering inflammatory effects of the Chikungunya virus.
The treatment protocol involved applying the coMra Delta to the affected joints using a combination of 50 Hz for five minutes, followed by 5 Hz for five minutes. As the patient progressed, the treatment duration was increased to ten minutes per session to further support the healing process.
The results of the coMra therapy were significant. After only two treatments, the patient’s pain score dropped from an eight to a five, and she regained the ability to walk without difficulty. Prior to this intervention, the patient’s mobility was so restricted that she could only take a few steps before needing to stop and rest due to intense pain.
Following eight treatments, her improvement was substantial enough to allow her to travel – an activity that had previously been impossible. Before beginning coMra therapy, the severity of her pain prevented her from sitting on an airplane for any extended period. Now, with her mobility restored, she has been able to embark on her travels. The clinical team plans to continue follow-up treatments to ensure sustained recovery and monitor her long-term progress.